# National Bankshares Inc: financial statements, quarterly

NKSH · Nasdaq · CIK 796534 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nksh.md) · [Financials](/companies/nksh/financials.md) · [Filings](/companies/nksh/filings.md) · [Insiders](/companies/nksh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nksh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [1,835](/filings/0000950170-24-126420.md) | [1,702 d](/filings/0000950170-25-046763.md) | [1,903](/filings/0000950170-25-071488.md) | [1,827](/filings/0000950170-25-107923.md) | [1,875](/filings/0001193125-25-279374.md) | [1,846 d](/filings/0001193125-26-128311.md) | [2,132](/filings/0001193125-26-220869.md) | [1,921](/filings/0001193125-26-346967.md) | [2,078](/filings/0001193125-25-279374.md) | [2,046 d](/filings/0001193125-26-128311.md) | [2,208](/filings/0001193125-26-220869.md) | [2,178](/filings/0001193125-26-346967.md) |
| Interest expense | $k | [6,039](/filings/0001437749-23-030806.md) | [7,033 d](/filings/0001437749-24-008428.md) | [7,776](/filings/0001437749-24-016875.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [617](/filings/0000950170-24-126420.md) | [879 d](/filings/0000950170-25-046763.md) | [518](/filings/0000950170-25-071488.md) | [(178)](/filings/0000950170-25-107923.md) | [550](/filings/0001193125-25-279374.md) | [608 d](/filings/0001193125-26-128311.md) | [666](/filings/0001193125-26-220869.md) | [362](/filings/0001193125-26-346967.md) | [961](/filings/0001193125-25-279374.md) | [1,351 d](/filings/0001193125-26-128311.md) | [1,066](/filings/0001193125-26-220869.md) | [1,048](/filings/0001193125-26-346967.md) |
| Net income | $k | [3,074](/filings/0000950170-24-126420.md) | [4,185 d](/filings/0000950170-25-046763.md) | [2,174](/filings/0000950170-25-071488.md) | [(307)](/filings/0000950170-25-107923.md) | [2,677](/filings/0001193125-25-279374.md) | [3,079 d](/filings/0001193125-26-128311.md) | [3,236](/filings/0001193125-26-220869.md) | [2,289](/filings/0001193125-26-346967.md) | [4,420](/filings/0001193125-25-279374.md) | [5,881 d](/filings/0001193125-26-128311.md) | [4,981](/filings/0001193125-26-220869.md) | [5,029](/filings/0001193125-26-346967.md) |
| Diluted EPS | $ per share | [0.52](/filings/0000950170-24-126420.md) | not reported | [0.37](/filings/0000950170-25-071488.md) | [(0.05)](/filings/0000950170-25-107923.md) | [0.42](/filings/0001193125-25-279374.md) | not reported | [0.51](/filings/0001193125-26-220869.md) | [0.36](/filings/0001193125-26-346967.md) | [0.69](/filings/0001193125-25-279374.md) | not reported | [0.78](/filings/0001193125-26-220869.md) | [0.79](/filings/0001193125-26-346967.md) |
| Basic EPS | $ per share | [0.52](/filings/0000950170-24-126420.md) | not reported | [0.37](/filings/0000950170-25-071488.md) | [(0.05)](/filings/0000950170-25-107923.md) | [0.42](/filings/0001193125-25-279374.md) | not reported | [0.51](/filings/0001193125-26-220869.md) | [0.36](/filings/0001193125-26-346967.md) | [0.70](/filings/0001193125-25-279374.md) | not reported | [0.78](/filings/0001193125-26-220869.md) | [0.79](/filings/0001193125-26-346967.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [86.6](/filings/0000950170-25-046763.md) | [121](/filings/0001437749-24-016875.md) | [98.9](/filings/0001437749-24-026741.md) | [49.8](/filings/0000950170-24-126420.md) | [108](/filings/0001193125-26-128311.md) | [123](/filings/0000950170-25-071488.md) | [92.8](/filings/0000950170-25-107923.md) | [42.3](/filings/0001193125-25-279374.md) | [59.3](/filings/0001193125-26-346967.md) | [62.2](/filings/0001193125-26-220869.md) | [54.6](/filings/0001193125-26-346967.md) |
| Total assets | $m | [1,592](/filings/0001437749-23-030806.md) | [1,655](/filings/0000950170-25-046763.md) | [1,689](/filings/0001437749-24-016875.md) | [1,809](/filings/0001437749-24-026741.md) | [1,785](/filings/0000950170-24-126420.md) | [1,812](/filings/0001193125-26-128311.md) | [1,836](/filings/0000950170-25-071488.md) | [1,807](/filings/0000950170-25-107923.md) | [1,802](/filings/0001193125-25-279374.md) | [1,825](/filings/0001193125-26-346967.md) | [1,829](/filings/0001193125-26-220869.md) | [1,833](/filings/0001193125-26-346967.md) |
| Total liabilities | $m | [1,476](/filings/0001437749-23-030806.md) | [1,515](/filings/0000950170-25-046763.md) | [1,550](/filings/0001437749-24-016875.md) | [1,660](/filings/0001437749-24-026741.md) | [1,617](/filings/0000950170-24-126420.md) | [1,655](/filings/0001193125-26-128311.md) | [1,668](/filings/0000950170-25-071488.md) | [1,638](/filings/0000950170-25-107923.md) | [1,623](/filings/0001193125-25-279374.md) | [1,640](/filings/0001193125-26-346967.md) | [1,642](/filings/0001193125-26-220869.md) | [1,640](/filings/0001193125-26-346967.md) |
| Shareholders' equity | $m | [116](/filings/0000950170-24-126420.md) | [141](/filings/0001193125-26-128311.md) | [139](/filings/0000950170-25-107923.md) | [149](/filings/0001193125-25-279374.md) | [168](/filings/0001193125-25-279374.md) | [156](/filings/0001193125-26-346967.md) | [167](/filings/0001193125-26-346967.md) | [169](/filings/0001193125-26-346967.md) | [179](/filings/0001193125-25-279374.md) | [185](/filings/0001193125-26-346967.md) | [187](/filings/0001193125-26-346967.md) | [192](/filings/0001193125-26-346967.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [5,660 d](/filings/0000950170-24-126420.md) | [2,191 d](/filings/0000950170-25-046763.md) | [3,840](/filings/0000950170-25-071488.md) | [(2,958) d](/filings/0000950170-25-107923.md) | [3,138 d](/filings/0001193125-25-279374.md) | [5,418 d](/filings/0001193125-26-128311.md) | [2,566](/filings/0001193125-26-220869.md) | [2,067 d](/filings/0001193125-26-346967.md) | [6,115 d](/filings/0001193125-25-279374.md) | [7,142 d](/filings/0001193125-26-128311.md) | [3,300](/filings/0001193125-26-220869.md) | [3,512 d](/filings/0001193125-26-346967.md) |
| Capital expenditure | $k | not reported | [228 d](/filings/0001437749-24-008428.md) | [315](/filings/0000950170-25-071488.md) | [1,016 d](/filings/0000950170-25-107923.md) | [971 d](/filings/0001193125-25-279374.md) | [954 d](/filings/0001193125-26-128311.md) | [963](/filings/0001193125-26-220869.md) | [543 d](/filings/0001193125-26-346967.md) | [800 d](/filings/0001193125-25-279374.md) | [432 d](/filings/0001193125-26-128311.md) | [229](/filings/0001193125-26-220869.md) | [190 d](/filings/0001193125-26-346967.md) |
| Dividends paid | $k | [0.0 d](/filings/0000950170-24-126420.md) | [4,595 d](/filings/0000950170-25-046763.md) | [0.0](/filings/0001437749-24-016875.md) | [4,302 d](/filings/0000950170-25-107923.md) | [1.0 d](/filings/0001193125-25-279374.md) | [4,961 d](/filings/0001193125-26-128311.md) | not reported | not reported | [0.0 d](/filings/0001193125-25-279374.md) | [4,966 d](/filings/0001193125-26-128311.md) | not reported | not reported |
| Share repurchases | $k | [0.0 d](/filings/0001437749-23-030806.md) | [0.0 d](/filings/0001437749-24-008428.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,975](/filings/0001437749-23-030806.md) | [5,890](/filings/0001437749-24-016875.md) | [5,890](/filings/0001437749-24-026741.md) | [5,890](/filings/0000950170-24-126420.md) | [5,892](/filings/0000950170-25-071488.md) | [6,028](/filings/0000950170-25-107923.md) | [6,358](/filings/0001193125-25-279374.md) | [6,360](/filings/0001193125-26-220869.md) | [6,362](/filings/0001193125-26-346967.md) | [6,363](/filings/0001193125-25-279374.md) | [6,366](/filings/0001193125-26-220869.md) | [6,367](/filings/0001193125-26-346967.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,370,620 at 2026-08-12, from the cover of the [10-Q filed 2026-08-12](/filings/0001193125-26-346967.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.